Cadre Holdings, Inc. income statement CDRE

In fiscal 2025, which ended Dec 31, 2025, Cadre Holdings, Inc. reported revenue of $610.3 million, up 7.5% from the year before. Net income was $44.1 million, a profit margin of 7.2%. Operating income came to $67.4 million, an operating margin of 11.0%. Diluted earnings per share were $1.02. Over the twelve months ended Sep 30, 2026, revenue was $732.7 million and net income was $41.1 million. Across the 5 fiscal years shown, revenue grew from $427.3 million in fiscal 2021 to $610.3 million in fiscal 2025, about 9.3% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2026
Sep 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
733
+18.3%
610
+7.5%
568
+17.6%
483
+5.4%
458
+7.1%
427
Cost of revenue
425
+19.7%
351
+5.0%
334
+18.5%
282
-0.1%
282
+10.0%
257
Gross profit
308
+16.6%
260
+11.2%
233
+16.3%
201
+14.3%
176
+2.9%
171
Research and development
—
11
+36.0%
8
+20.5%
7
-1.9%
7
+9.7%
6
Selling, general and administrative
222
+24.8%
183
+15.7%
158
+12.7%
141
-8.2%
153
+33.2%
115
Operating income
79
+3.2%
67
+0.9%
67
+18.1%
57
+238.1%
17
-67.7%
52
Other income (expense)
-17
-94.7%
-5
+59.9%
-13
-248.9%
-4
+51.0%
-7
+77.4%
-33
Pretax income
61
-9.0%
62
+15.0%
54
+2.4%
53
+464.6%
9
-51.2%
19
Income tax
20
-8.0%
18
+0.6%
18
+26.6%
14
+302.0%
4
-45.6%
7
Net income
41
-9.4%
44
+22.2%
36
-6.5%
39
+563.9%
6
-54.0%
13
Basic EPS
0.97
-13.3%
1.08
+20.0%
0.90
-12.6%
1.03
+543.8%
0.16
-63.6%
0.44
Diluted EPS
0.91
-18.0%
1.02
+13.3%
0.90
-11.8%
1.02
+537.5%
0.16
-63.6%
0.44
Weighted average shares, basic
42
+4.4%
41
+2.3%
40
+6.4%
38
+3.9%
36
+26.3%
29
Weighted average shares, diluted
45
+10.5%
43
+7.7%
40
+6.4%
38
+5.0%
36
+26.3%
29
Other measures
Depreciation and amortization
23
+28.1%
19
+13.5%
16
+4.3%
16
+0.5%
16
+14.1%
14
EBITDA
102
+7.9%
86
+3.4%
83
+15.1%
72
+123.2%
32
-50.5%
65
Interest coverage
—
—
8.54x
—
—
—
Margins
Gross margin
42.04%
42.54%
41.14%
41.60%
38.37%
39.95%
Operating margin
10.75%
11.04%
11.76%
11.71%
3.65%
12.10%
Pretax margin
8.37%
10.21%
9.55%
10.97%
2.05%
4.49%
Profit margin
5.61%
7.23%
6.37%
8.01%
1.27%
2.96%
EBITDA margin
13.90%
14.09%
14.66%
14.97%
7.07%
15.31%
Effective tax rate
32.99%
29.18%
33.36%
26.99%
37.91%
34.03%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
CDRE (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Jacksonville, FL
SEC filer status
, Emerging growth company
SEC CIK
1860543

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.